
Join Dr Rohit Gupta as we discuss second line treatment for PBC covering treatment, impact on symptoms, advanced cirrhosis and managing patients on fenofibrate.
With Elafibranor and Seladelpar changing the landscape perfect time to learn more.
Elafibranor: https://www.nejm.org/doi/full/10.1056/NEJMoa2312100
Seladelpar:
https://www.nejm.org/doi/10.1056/NEJMoa2312100?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed